Atlas Trials

Meningococcal B Disease

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Meningococcal B Disease

RecordFirmDate
Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers. (NCT02534935)Pfizer2015-08-31

Track Meningococcal B Disease automatically

Every clearance here is in the API, with alerts when new ones post.